Physician

Hematology

Michael Frontiera is an expert in the field of Hematology. He went to University of Kansas School of Medicine. He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Dr. Michael S. Frontiera is also a published doctor. He has 9 publication published. The most recent publication is: A phase II study of menogaril (7R-O-methylnogarol) in patients with relapsed/refractory acute myeloid leukemia: a study of the Eastern Cooperative Oncology Group. Michael Frontiera accepts Medicare payments and is listed with Medicare.gov.

Publications

---

• Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon Cancer: final report of Intergroup 0089.
• A phase II study of menogaril (7R-O-methylnogarol) in patients with relapsed/refractory Acute myeloid leukemia: a study of the Eastern Cooperative Oncology Group.
• Peripheral blood and bone marrow abnormalities in the acquired immunodeficiency syndrome.
• Sequential use of indium-111 labeled monoclonal antibodies 96.5 and ZME-018 does not increase detection sensitivity for metastatic Melanoma.
• Randomized phase II-III trial of combination beta and gamma interferons and etoposide and cisplatin in inoperable non-small cell Cancer of the lung.
• Cisplatin, carboplatin, and cyclophosphamide combination chemotherapy in advanced-stage ovarian Carcinoma: an Eastern Cooperative Oncology Group pilot study.
• Justification for evaluating new antiCancer drugs in selected untreated patients with extensive-stage small-cell lung Cancer: an Eastern Cooperative Oncology Group ran...
• A randomized phase II study of paclitaxel and bevacizumab with and without gemcitabine as first-line treatment for metastatic breast Cancer.

Schools

---

• University of Kansas School of Medicine

• Valley Med Center

• University Of Colorado

Conditions Treated

---

• Acute Leukemia
• Anal and Rectal Cancer
• Anemia
• Basal Cell Carcinoma
• View All

Doctors Specialties

---

• Medical Oncology
• Oncology
• Hematology

Accepted Insurances

---

Awards

---

• CMS Meaningful Use Stage 1 Certification

Education

---

• University of Colorado
• University of Kansas School of Medicine

Drug Facts

---

NPI NUMBER		1669428017
NPPES Provider LastName		FRONTIERA
NPPES Provider FirstName		MICHAEL
NPPES Provider ZIPCode		537171967
NPPES Provider State		WI
Specialty Description		Hematology/Oncology
Total Claim Count		1142.0
Distinct Opioid Count		6.0
Opioid Claim Count		155.0
Percent Opioid Claims		13.57

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1669428017
Last Name Of The Provider	FRONTIERA
First Name Of The Provider	MICHAEL
View All

Similar Doctors

---

	Dr. Aric C. Hall, MD This Doctor is OpenDoctor Recommended.
	Dr. Robert B. Hegeman, MD This Doctor is OpenDoctor Recommended.
	Dr. Natalie S. Callander, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Edward J. Prendergast, MD This Doctor is OpenDoctor Recommended.
	Dr. Lisa M. Lepeak, MD This Doctor is OpenDoctor Recommended.
	Dr. H I. Robins, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Brad S. Kahl, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Joshua M. Lang, MD This Doctor is OpenDoctor Recommended.
	Dr. Eliot C. Williams, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Julie E. Chang, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. George Wilding, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Kae I. Walker, MD This Doctor is OpenDoctor Recommended.
	Dr. David L. Hei, MD This Doctor is OpenDoctor Recommended.
	Dr. Tien Hoang, MD This Doctor is OpenDoctor Recommended.
	Dr. Alissa A. Weber, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog